ADC Therapeutics SA
Utility Patents

Last updated:

List of all ADC Therapeutics SA patents 7 in total

Status Patent
Grant
Utility: Pyrrolobenzodiazepine-antibody conjugates External link
Filling date: 6 Sep 2025 Issue date: 12 Jul 2022
Grant
Utility: Dosage regimes for the administration of an anti-CD19 ADC External link
Filling date: 6 Sep 2025 Issue date: 3 May 2022
Grant
Utility: Pyrrolobenzodiazepine-antibody conjugates External link
Filling date: 6 Sep 2025 Issue date: 2 Nov 2021
Grant
Utility: Method for treating breast cancer External link
Filling date: 6 Sep 2025 Issue date: 10 Aug 2021
Grant
Utility: Pyrrolobenzodiazepine-antibody conjugates External link
Filling date: 6 Sep 2025 Issue date: 22 Sep 2020
Grant
Utility: Antibodies against kidney associated antigen 1 and antigen binding fragments thereof External link
Filling date: 6 Sep 2025 Issue date: 24 Mar 2020
Grant
Utility: Combination therapy with an anti-axl antibody-drug conjugate External link
Filling date: 6 Sep 2025 Issue date: 28 Jan 2020

Showing 1 to 7 of 7 patents.